Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex
Open Access
- 3 December 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Abstract
Antibody drugs exert therapeutic effects via a range of mechanisms, including competitive inhibition, allosteric modulation, and immune effector mechanisms. Facilitated dissociation is an additional mechanism where antibody-mediated “disruption” of stable high-affinity macromolecular complexes can potentially enhance therapeutic efficacy. However, this mechanism is not well understood or utilized therapeutically. Here, we investigate and engineer the weak disruptive activity of an existing therapeutic antibody, omalizumab, which targets IgE antibodies to block the allergic response. We develop a yeast display approach to select for and engineer antibody disruptive efficiency and generate potent omalizumab variants that dissociate receptor-bound IgE. We determine a low resolution cryo-EM structure of a transient disruption intermediate containing the IgE-Fc, its partially dissociated receptor and an antibody inhibitor. Our results provide a conceptual framework for engineering disruptive inhibitors for other targets, insights into the failure in clinical trials of the previous high affinity omalizumab HAE variant and anti-IgE antibodies that safely and rapidly disarm allergic effector cells.Keywords
Funding Information
- Fondation Acteria
- Uniscientia Stiftung
- Research Fund of the Swiss Lung Foundation
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI120510, AI115469)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL141493)
This publication has 46 references indexed in Scilit:
- Accelerated disassembly of IgE–receptor complexes by a disruptive macromolecular inhibitorNature, 2012
- Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcεRIProceedings of the National Academy of Sciences, 2012
- Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRINature Structural & Molecular Biology, 2011
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- Integration, scaling, space-group assignment and post-refinementActa Crystallographica Section D Structural Biology, 2010
- Conformational Flexibility in Immunoglobulin E-Fc3–4 Revealed in Multiple Crystal FormsJournal of Molecular Biology, 2009
- Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE‐mediated) asthmaBritish Journal of Clinical Pharmacology, 2009
- Automated electron microscope tomography using robust prediction of specimen movementsJournal of Structural Biology, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004